Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Benefit and harm of pregabalin in acute pain treatment: a systematic review with meta-analyses and trial sequential analyses

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Front of neck: continued discovery of this anatomy essential for airway management

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Hyperoxia is a modifiable anaesthetic risk factor that varies in the practice of individual anaesthetists

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Short-stay unit hospitalisation vs. standard care outcomes in older internal medicine patients-a randomised clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The Impact of Intraoperative Fluid Therapy and Body Temperature on Surgical Site Infection - Re-Assessment of a Randomized Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Timing of surgical site infection and pulmonary complications after laparotomy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Pregabalin has demonstrated anti-hyperalgesic properties and was introduced into acute pain treatment in 2001. Our aim was to evaluate the beneficial and harmful effects of pregabalin in postoperative pain management. We included randomized clinical trials investigating perioperative pregabalin treatment in adult surgical patients. The review followed Cochrane methodology, including Grading of Recommendations Assessment, Development, and Evaluation (GRADE), and used trial sequential analyses (TSAs). The primary outcomes were 24 h morphine i.v. consumption and the incidence of serious adverse events (SAEs) defined by International Conference of Harmonisation Good Clinical Practice guidelines. Conclusions were based primarily on trials with low risk of bias. Ninety-seven randomized clinical trials with 7201 patients were included. The 24 h morphine i.v. consumption was reported in 11 trials with overall low risk of bias, finding a reduction of 5.8 mg (3.2, 8.5; TSA adjusted confidence interval: 3.2, 8.5). Incidence of SAEs was reported in 21 trials, with 55 SAEs reported in 12 of these trials, and 22 SAEs reported in 10 trials with overall low risk of bias. In trials with overall low risk of bias, Peto's odds ratio was 2.9 (1.2, 6.8; TSA adjusted confidence interval: 0.1, 97.1). Based on trials with low risk of bias, pregabalin may have a minimal opioid-sparing effect, but the risk of SAEs seems increased. However, the GRADE-rated evaluations showed only moderate to very low quality of evidence. Consequently, a routine use of pregabalin for postoperative pain treatment cannot be recommended.

OriginalsprogEngelsk
TidsskriftBritish Journal of Anaesthesia
Vol/bind119
Tidsskriftsnummer4
Sider (fra-til)775-791
Antal sider17
ISSN0007-0912
DOI
StatusUdgivet - 1 okt. 2017

ID: 52101390